Biofrontera Inc. (BFRI) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Biofrontera Inc. (BFRI) reported a Q3 loss of $0.86 per share, missing the Zacks Consensus Estimate of a $0.73 loss. This is an improvement from the $4.64 loss per share a year ago.
November 14, 2024 | 1:30 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biofrontera Inc. reported a Q3 loss of $0.86 per share, which was worse than the expected loss of $0.73 per share. Despite this, the loss is an improvement from the previous year's $4.64 per share.
The reported loss per share was worse than expected, which is typically negative for stock prices. However, the improvement from last year's loss may mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100